<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002665'>Lymphoma</z:hpo> is a highly <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of malignant disease </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to elucidate the pattern of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in the East Malaysian patient population </plain></SENT>
<SENT sid="2" pm="."><plain>107 cases of confirmed <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from East Malaysian biopsy material were retrieved from the files of the Department of Pathology, University of Malaya, in the 3-year period between 1981 to 1983 </plain></SENT>
<SENT sid="3" pm="."><plain>With the use of a panel of lymphoid antibodies, the disease was sub-classified using the Rye classification for Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>) and the REAL classification for non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the cases were tested for the presence of the Epstein-Barr virus by EBER-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>There were 11 (10.3%) <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, 80 (74.7%) B-NHL and 16 (15%) T-NHL </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>:NHL ratio was 1:9 </plain></SENT>
<SENT sid="7" pm="."><plain>The most <z:e sem="disease" ids="C1333132" disease_type="Neoplastic Process" abbrv="">common tumour</z:e> in children was Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 7/13 (53.8%) </plain></SENT>
<SENT sid="8" pm="."><plain>In the adult group, there were 72/94 (76.6%) B-NHL ¿diffuse large cell type 51 (of which 2 were CD30+), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 8, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 5, low grade MALT 2, mantle cell type 1 and not otherwise specified due to poor <z:mp ids='MP_0000002'>morphology</z:mp> 5¿, 13/94 (13.8%) T-NHL and 9/94 (9.6%) <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Of the 9 adult <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, the most common subtype was nodular <z:mp ids='MP_0000612'>sclerosis</z:mp> (6, 66.7%) </plain></SENT>
<SENT sid="10" pm="."><plain>The EBER positive rate in classical <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>, T-NHL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and B-NHL were 33.3%, 56.3%, 60.0% and 3.1% respectively </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, the spectrum of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> seen in East Malaysia was rather similar to West Malaysia except for the very low prevalence of peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>) in Sarawak (3.3%) </plain></SENT>
</text></document>